- Home
- MHK vs RGEN Comparison
MHK vs RGEN Comparison
Compare MHK & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHK
- RGEN
- Stock Information
- Founded
- MHK 1988
- RGEN 1981
- Country
- MHK United States
- RGEN United States
- Employees
- MHK N/A
- RGEN N/A
- Industry
- MHK Home Furnishings
- RGEN Medical/Dental Instruments
- Sector
- MHK Consumer Discretionary
- RGEN Health Care
- Exchange
- MHK Nasdaq
- RGEN Nasdaq
- Market Cap
- MHK 9.7B
- RGEN 8.2B
- IPO Year
- MHK 1992
- RGEN N/A
- Fundamental
- Price
- MHK $155.79
- RGEN $140.00
- Analyst Decision
- MHK Buy
- RGEN Buy
- Analyst Count
- MHK 12
- RGEN 10
- Target Price
- MHK $156.58
- RGEN $188.38
- AVG Volume (30 Days)
- MHK 509.1K
- RGEN 783.2K
- Earning Date
- MHK 10-24-2024
- RGEN 10-29-2024
- Dividend Yield
- MHK N/A
- RGEN N/A
- EPS Growth
- MHK N/A
- RGEN N/A
- EPS
- MHK N/A
- RGEN N/A
- Revenue
- MHK $10,859,115,000.00
- RGEN $602,354,000.00
- Revenue This Year
- MHK N/A
- RGEN $0.08
- Revenue Next Year
- MHK $2.50
- RGEN $12.97
- P/E Ratio
- MHK N/A
- RGEN N/A
- Revenue Growth
- MHK N/A
- RGEN N/A
- 52 Week Low
- MHK $76.02
- RGEN $110.45
- 52 Week High
- MHK $164.06
- RGEN $211.13
- Technical
- Relative Strength Index (RSI)
- MHK 61.22
- RGEN 41.03
- Support Level
- MHK $145.00
- RGEN $138.80
- Resistance Level
- MHK $152.06
- RGEN $150.72
- Average True Range (ATR)
- MHK 3.69
- RGEN 5.04
- MACD
- MHK -0.28
- RGEN -1.06
- Stochastic Oscillator
- MHK 82.59
- RGEN 8.50
About MHK Mohawk Industries Inc.
Mohawk Industries Inc manufactures a wide range of flooring products, including carpets, rugs, ceramic tile, laminate, wood, luxury vinyl tile, and vinyl flooring. Its operating segments include Global Ceramic, Flooring North America, and Flooring Rest of the World. The company generates maximum revenue from the Global Ceramic segment. Geographically, it derives a majority of its revenue from the United States.
About RGEN Repligen Corporation
Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.